Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher D. Gocke
Christopher D. Gocke
Johns Hopkins University
Internal medicine
Oncology
Cancer research
Immunology
Medicine
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers
2019
Clinical Cancer Research
Razelle Kurzrock
Douglas W. Ball
Marianna Zahurak
Barry D. Nelkin
Vivek Subbiah
Shabina Ahmed
Ashley O'Connor
Enusha Karunsena
Rose Parkinson
Justin A. Bishop
Yoonji Ha
Rajni Sharma
Christopher D. Gocke
Ralph G Zinner
Michelle A. Rudek
Steven I. Sherman
Nilofer Azad
Show All
Source
Cite
Save
Citations (0)
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation
2019
Biology of Blood and Marrow Transplantation
Keith W. Pratz
Michelle A. Rudek
B. Douglas Smith
Judith E. Karp
Ivana Gojo
Amy E. DeZern
Richard J. Jones
Jackie Greer
Christopher D. Gocke
Maria R. Baer
Vu H. Duong
Gary L. Rosner
Marianna Zahurak
John J. Wright
Ashkan Emadi
Mark J. Levis
Show All
Source
Cite
Save
Citations (0)
Development of a Novel Next-Generation Sequencing (NGS)-Based Assay for Measurable Residual Disease (MRD) in FLT3 -ITD AML and Its Potential Clinical Application in Patients Treated with Chemotherapy Plus FLT3 Inhibitors
2018
Blood
Mark J. Levis
Wenge Shi
Ken Cn Chang
Christian Laing
Flora Berisha
Emily Adams
Christopher D. Gocke
Wei Ding
Kenji Nakamaru
Jelveh Lameh
Reinhold Pollner
Ken Kobayashi
Show All
Source
Cite
Save
Citations (2)
1